TMune Therapeutics Overview
- Year Founded
-
2008

- Status
-
Private
- Latest Deal Type
-
Buyout/LBO
- Latest Deal Amount
-
$1.5M
- Investors
-
2
TMune Therapeutics General Information
Description
Developer of T-cell therapies designed to treat cancer. The company's therapies help in the treatment of cancer, lymphoma, HIV, and other infectious diseases, enabling patients to get cured and lead a healthy life.
Contact Information
Corporate Office
- 2119 Delancey Street
- Philadelphia, PA 19103
- United States
Corporate Office
- 2119 Delancey Street
- Philadelphia, PA 19103
- United States
TMune Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Buyout/LBO | 03-Jan-2012 | $1.5M | Completed | Startup | ||
2. Grant | 01-Jan-2009 | Completed | Startup | |||
1. Early Stage VC (Series A) | 29-Feb-2008 | $13M | $13M | Completed | Startup |
TMune Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A |
TMune Therapeutics Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Biomark Capital | PE/Buyout | Majority | ||
National Institutes of Health | Government |
TMune Therapeutics FAQs
-
When was TMune Therapeutics founded?
TMune Therapeutics was founded in 2008.
-
Where is TMune Therapeutics headquartered?
TMune Therapeutics is headquartered in Philadelphia, PA.
-
What industry is TMune Therapeutics in?
TMune Therapeutics’s primary industry is Drug Discovery.
-
Is TMune Therapeutics a private or public company?
TMune Therapeutics is a Private company.
-
What is the current valuation of TMune Therapeutics?
The current valuation of TMune Therapeutics is
. -
What is TMune Therapeutics’s current revenue?
The current revenue for TMune Therapeutics is
. -
How much funding has TMune Therapeutics raised over time?
TMune Therapeutics has raised $13M.
-
Who are TMune Therapeutics’s investors?
Biomark Capital and National Institutes of Health have invested in TMune Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »